On February 13, 2024, Allarity Therapeutics, Inc. closed the transaction.The company raised a senior convertible promissory note for the gross proceeds of $400,000 in its second and final tranche.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.38 USD | -5.48% | -2.82% | -87.48% |
Apr. 15 | Top Premarket Gainers | MT |
Apr. 12 | Top Premarket Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.48% | 426K | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.46% | 22.18B | |
-16.67% | 21.2B | |
-8.58% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- ALLR Stock
- News Allarity Therapeutics, Inc.
- Allarity Therapeutics, Inc. announced that it has received $0.8 million in funding from 3i, LP